期刊文献+

拜阿司匹林对小鼠主动脉核转录因子-κB与基质金属蛋白酶-9表达的调控

Effect of β-Aspirin on matrix metalloproteinase-9 and nuclear factor kBp65 expression in aortic artery of atherosclerostic mouse
下载PDF
导出
摘要 目的:观察拜阿司匹林对小鼠主动脉核转录因子-κB(NF-κB)与基质金属蛋白酶-9(MMP-9)表达的调控作用。方法:40只13周龄小鼠分为拜阿司匹林组(给高脂饲料,拜阿司匹林6mg/kg灌胃),氟伐他汀组(给高脂饲料,氟伐他汀3mg/kg灌胃),模型组(给高脂饲料,生理盐水1ml灌胃),正常对照组(给予普通饲料,生理盐水1ml灌胃),每组10只,17周后,取主动脉,以免疫组化法观察其NF-κB和MMP-9表达的程度。结果:较之对照组模型组,小鼠主动脉粥样斑块的NF-κB与MMP-9表达明显增加,拜阿司匹林组和氟伐他汀组均显著降低其表达(P均<0.01),拜阿司匹林组和氟伐他汀组间其表达水平无显著差异(P>0.05)。结论:拜阿司匹林可以降低NF-κB与MMP-9的表达,从而抑制血管内炎症反应和基质纤维蛋白的降解,起到治疗动脉粥样硬化的作用。 ObjectiveS. To study the effects ofβ--aspirin on expression of matrix metalloproteinase--9 (MMP--9) and nuclear factor κB (NF--κB). Methods.. Forty mouse with the age of thirteen weeks were averagely divided into normal control group, model group, β--aspirin group, fluvastatin group. The mouse of model group, β--aspirin group, fluvastatin group were received the high lipid diet, and the normal control group received the normal diet. In the same time, the β--aspirin group was treated with aspirin intragastric administration 6 mg/kg; the fluvastatin group with fluvastatin intragastric administration 3 mg/kg. Seventeen-week after treatment, expression of MMP--9 and NF--κB in aorta was detected by immunohistochemistry. Results: Compared with normal control group, the expression of MMP --9 and NF--κB significantly increased (P〈0.01) in model group. In β--aspirin group and fluvastatin group the expression of MMP--9 and NF--κB significantly decreased compared with those of model group (P〈0.01). The expression of MMP--9 and NF-κB was no difference between β--aspirin group and the fluvastatin group (P〉0.05) Conclusion. β-- aspirin can inhibits the expression of MMP-- 9 and NF-- κB, so may increases the stability of plaques;
出处 《心血管康复医学杂志》 CAS 2008年第5期482-484,F0002,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 阿司匹林 转录因子 基质金属蛋白酶 Aspirin Transcription factor Matrix metalloproteinase
  • 相关文献

参考文献12

  • 1郭爱桃,韦立新,李向红.冠状动脉粥样硬化斑块组成成分与斑块破裂的关系[J].中国动脉硬化杂志,1999,7(4):357-359. 被引量:36
  • 2de Nooijer R, Verklej CJ, Von der Thusen JH, et al. Lesional overexpression of matrix metallo proteinase- 9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis [J]. Arterioscler Thromb Vase Bio, 2006, 26 (2): 340-346.
  • 3Ross R. Atherosclerosis is an inflammatory disease [J]. Am Heart, 1999, 138 (5): 419-420.
  • 4Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis, the good, the bad, and ugly [J]. Circ Res, 2002, 90 (3):251-262.
  • 5Lee RT, Schoen FJ, Loree HM, et al. Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis: implication for plaque rupture[J]. Arterioscler Thromb Vasc Biol, 1996, 16 (8):1070-1073.
  • 6Ambrose JA, Martinez EE. A new paradigm for plaque stabilization [J]. Circulation, 2002, 105 (16): 2000-2004.
  • 7Molnaco C, Palcrolog E. Nuclear factor kappa B: a potential therapeutic target in atherosclerosis and thrombosis [J]. Cardiovase Res2004, 61 (4): 671-682.
  • 8Lopez-Franco O, Hernandez-Vargas P, Ortiz-Munoz G, et al. Parthenolide modulates the NF-kappa B-mediated inflammtatory responses in experimental atherosclerosis [J]. Arterioscler Thromb Vasc Biol, 2006, 26 (8): Ⅰ864-Ⅰ870.
  • 9Brand K, Page S, Rogler G, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotie lesion [J]. ClinInvest, 1996, 97 (7): 1715-1722.
  • 10Kopp E, Ghosh S. Inhibition of NF-κB by sodium salieylate and asipirin [J]. Science, 1994, 265 (12): 956-959.

二级参考文献30

  • 1顾晴,陈纪林,阮英茆.阿司匹林、氯吡格雷及合用对兔动脉粥样硬化病变进展的抑制作用[J].中国医学科学院学报,2005,27(1):87-91. 被引量:46
  • 2Libby P,Rkdker PM,Maseri A.Inflammation and atherosclerosis.Circulation,2002,105:1135-1143.
  • 3Huo Y,Schober A,Forlow SB,et al.Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.Nature Medcine,2003,9:61-67.
  • 4Cyrus T,Sung S,Zhao L,et al.Effect of low-dose aspirin on vascular inflammation,plaque stability,and atherogenesis in low-density lipoprotein receptor-deficient mice.Circulation,2002,106:1282-1287.
  • 5Andre P,Nannizzi-Alaimo L,Prasad SK,et al.Platelet-derived CD40L:the switch-hitting player of cardiovascular disease.Circulation,2002,106:896-899.
  • 6Yutaka N,Andrew SP,Elaine WR,et al.ApoE-dificient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.Arterioscler Thromb,1994,14:133-140.
  • 7Lu L,Li W,Fu F,et al.Blockade of the CD40-CD40L pathway potentiates the capacity of donor-drived dendritic cell progenitors to induce long-term cardiac allograft survival.Transplanatation,1997,64:1808-1815.
  • 8Mach F,Schonbeck U,Sukhova GK,et al.Functional CD40 ligand is expressed on human vascular endothelial cells,smooth muscle cells,and macrophages:Implication of CD40-CD40 ligand signaling in atherosclerosis.Proc Natl Acad Sci USA,1997,94:1931-1936.
  • 9Henn V,Slupsky JR,Grafe M,et al.CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells.Nature,1998,391:591-594.
  • 10Garlichs CD,Eskafi S,Raaz D,et al.Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.Heart,2001,86:649-655.

共引文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部